2.20Open2.20Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover157.62%IV-4.13%PremiumAug 16, 2024Expiry Date2.41Intrinsic Value100Multiplier24DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.7679Delta0.1478Gamma1.94Leverage Ratio-0.0121Theta-0.0035Rho-1.49Eff Leverage0.0041Vega
Applied Therapeutics Stock Discussion
$Applied Therapeutics(APLT.US)$
The biopharmaceutical company said Thursday that the Food and Drug Administration now has a target action date of Nov. 28 for its application, compared with the previous date of Aug. 28.
The company's application is for govorestat in the treatment of Galactosemia, a rare genetic condition that makes patients unable to metab...
In a significant development for the healthcare sector and investors worldwide, Applied Therapeutics Inc. (NASDAQ:APLT), a clinical-stage biopharmaceutical company, has announced the Food and Drug Administration's acceptance and priority review of t...
No comment yet